Company Information

Operating, investing and financing cash flows.

Cash Flow

REMUS PHARMACEUTICALS LTD.

NSE Code: REMUSSM
BSE Code: -
ISIN: INE0O5T01011
Industry: Pharmaceuticals

Financial Data

Cash Flow

All amounts are in ₹ crore unless stated otherwise.

Showing Standalone data

Five-year standalone Cash Flow for the selected company
Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00

Net Profit/Loss Before Extraordinary Items And Tax	33.23	26.64	22.52	11.41	4.55

Net CashFlow From Operating Activities	25.50	15.59	2.43	5.31	5.04
Net Cash Used In Investing Activities	-26.33	-12.42	-20.90	-15.19	-4.55
Net Cash Used From Financing Activities	0.13	-1.42	39.29	11.77	-0.17

Net Inc/Dec In Cash And Cash Equivalents	-0.70	1.75	20.81	1.89	0.32
Cash And Cash Equivalents Begin of Year	3.46	1.71	3.04	1.15	0.83
Cash And Cash Equivalents End Of Year	2.76	3.46	23.85	3.04	1.15

Five-year consolidated Cash Flow for the selected company
Particulars	Mar 26	Mar 25	Mar 24
Months	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR
FaceValue	10.00	10.00	10.00

Net Profit/Loss Before Extraordinary Items And Tax	59.16	47.34	31.83

Net CashFlow From Operating Activities	18.18	6.98	3.60
Net Cash Used In Investing Activities	-15.03	-10.55	-8.94
Net Cash Used From Financing Activities	1.45	6.08	24.37

Net Inc/Dec In Cash And Cash Equivalents	4.60	2.51	19.03
Cash And Cash Equivalents Begin of Year	7.23	4.72	7.84
Cash And Cash Equivalents End Of Year	11.83	7.23	26.87

Source: Financial statements as reported by the company.